References
- Malicki J. The importance of accurate treatment planning, delivery, and dose verification. Rep Pract Oncol Radiother 2012; 17: 63-5. 10.1016/j.rpor.2012.02.00124377001
- Palmer AL, Lee C, Ratcliffe AJ, Bradley D, Nisbet A. Design and implementation of a film dosimetry audit tool for comparison of planned and delivered dose distributions in high dose rate (HDR) brachytherapy. Phys Med Biol 2013; 58: 6623-40. 10.1088/0031-9155/58/19/662324018542
- Adamczyk M, Zwierzchowski G, Malicki J, Skowronek J. Evaluation of clinical benefits achievable by using different optimization algorithms during real time prostate brachytherapy. Phys Medica 2013; 29: 111-7. 10.1016/j.ejmp.2011.12.005
- Rivard MJ, Beaulieu L, Mourtada F. Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms. Med Phys 2010; 37: 2645-58. 10.1118/1.342913120632576
- Granero D, Vijande J, Ballester F, Rivard MJ. Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2. Med Phys 2011; 38: 487-94. 10.1118/1.353197321361217
- Perez-Calatayud J, Ballester F, Das RK, Dewerd LA, Ibbott GS, Meigooni AS, et al. Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: Report of the AAPM and ESTRO. Med Phys 2012; 39: 2904-29. 10.1118/1.370389222559663
- Brown T, Hogstrom RK. Dose-response curve of EBT, EBT2 and EBT3 radiochromic films to synchrotron-produced monochromatic x-ray beams, Med Phys 2012; 39: 7412-7. 10.1118/1.476777023231291
- Chiu-Tsao ST, Ho Y, Shankar R, Wang L, Harrison LB. Energy dependence of response of new high sensitivity radiochromic films for megavoltage and kilovoltage radiation energies, Med Phys 2005; 32: 3350-4. 10.1118/1.2016546716370422
- DeWerd LA, Ibbott GS, Meigooni AS. A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO. Med Phys 2011; 38: 782-801. 10.1118/1.353372021452716
- Hyer DE, Sheybani A, Jacobson GM, Kim Y. The dosimetric impact of heterogeneity corrections in high-dose rate (192)Ir brachytherapy for cervical cancer: investigation of both conventional Point-A and volume-optimized plans. Brachytherapy 2012; 11: 515-20. 10.1016/j.brachy.2012.01.011
- de Oliveira CA, Lopes MD, Matos A. Commissioning of brachytherapy module of Oncentra MasterPlan treatment planning system. J Contemp Brachyther 2009; 1: 224-30.
- Palmer A, Bradley D, Nisbet A. Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniques. J Contemp Brachytherapy 2012; 4: 81-91. 10.5114/jcb.2012.3255823349649
- Beaulieu L, Carlsson Tedgren A, Carrier JF, Davis SD, Mourtada F, Rivard MJ, et al. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. Med Phys 2012; 39: 6208-36. 10.1118/1.474726423039658
- Mikell JK, Klopp AH, Gonzalez GM, Kisling KD, Price MJ, Berner PA, et al. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 2012; 83: 417-22. 10.1016/j.ijrobp.2011.12.074
- Oliveira S, Teixeira N, Fernandes L, Teles P, Vaz P. Dosimetric effect of tissue heterogeneity for 125I prostate implants. Rep Pract Oncol Radiother 2014; 19: 392-8.10.1016/j.rpor.2014.03.004
- Awunor OA, Dixon B, Walker C. Direct reconstruction and associated uncertainties of 192Ir source dwell positions in ring applicators using gafchromic film in the treatment planning of HDR brachytherapy cervix patients. Phys Med Biol 2013; 58: 3207-25. 10.1088/0031-9155/58/10/320723603854
- Zwierzchowski G, Bielęda G, Skowronek J, Mazur M. Film based verification of calculation algorithms used for brachytherapy planning-getting ready for upcoming challenges of MBDCA. J Contemp Brachytherapy 2016; 8: 326-35. 10.5114/jcb.2016.6182827648087
- Singh K. Investigation of the energy response of EBT-2 gafchromic film model. Montreal: Department of Medical Physics, McGill University; 2011.
- Manikandan A, Biplab S, David PA, Holla R, Vivek TR, Sujatha N. Relative dosimetrical verification in high dose rate brachytherapy using two-dimensional detector array IMatriXX. J Med Phys 2011; 36: 171-5. 10.4103/0971-6203.8349121897562
- Vijande J, Ballester F, Ouhib Z, Granero D, Pujades-Claumarchirant MC, Perez-Calatayud J. Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy. Brachytherapy 2012; 11: 528-35. 10.1016/j.brachy.2011.11.00522226080
- Rivard MJ, Venselaar JL, Beaulieu L. The evolution of brachytherapy treatment planning. Med Phys 2009; 36: 2136-53. 10.1118/1.312513619610303
- Hira M, Podgorsak MB, Jaggernauth W, Malhotra HK. Measurement of dose perturbation around shielded ovoids in high-dose-rate brachytherapy. Brachytherapy 2011; 10: 232-41. 10.1016/j.brachy.2010.08.00820932810
- Uniyal SC, Sharma SD, Naithani UC. A dosimetry method in the transverse plane of HDR Ir-192 brachytherapy source using gafchromic EBT2 film. Phys Med 2012; 28: 129-33. 10.1016/j.ejmp.2011.03.00521507693
- Landry G, Reniers B, Murrer L, Lutgens L, Gurp EB, Pignol JP, et al. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition. Med Phys 2010; 37: 5188-98. 10.1118/1.347716121089752
- Kirisits C, Rivard MJ, Baltas D, Ballester F, De Brabandere M, van der Laarse R, et al. Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM. Radiother Oncol 2014; 110: 199-212. 10.1016/j.radonc.2013.11.00224299968
- Niatsetski Y, Fekkes S, Vreeken H. Source path measurements for ring applicators. [Abstract]. Radiother Oncol 2011; 99: 278. Poster No. 69510.1016/S0167-8140(11)70817-9
- Berger D, Dimopoulos J, Georg P, Georg D, Pötter R, Kirisits C. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. Int J Radiat Oncol Biol Phys 2007; 67: 1451-9. 10.1016/j.ijrobp.2006.11.02117289290